Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity

B Mittendorfer, BW Patterson… - American Journal of …, 2003 - journals.physiology.org
B Mittendorfer, BW Patterson, S Klein
American Journal of Physiology-Endocrinology and Metabolism, 2003journals.physiology.org
The effects of obesity and weight loss on lipoprotein kinetics were evaluated in six lean
women [body mass index (BMI): 21±1 kg/m2] and seven women with abdominal obesity
(BMI: 36±1 kg/m2). Stable isotope tracer techniques, in conjunction with compartmental
modeling, were used to determine VLDL-triglyceride (TG) and apolipoprotein B-100 (apoB-
100) secretion rates in lean women and in obese women before and after 10% weight loss.
VLDL-TG and VLDL-apoB-100 secretion rates were similar in lean and obese women …
The effects of obesity and weight loss on lipoprotein kinetics were evaluated in six lean women [body mass index (BMI): 21 ± 1 kg/m2] and seven women with abdominal obesity (BMI: 36 ± 1 kg/m2). Stable isotope tracer techniques, in conjunction with compartmental modeling, were used to determine VLDL-triglyceride (TG) and apolipoprotein B-100 (apoB-100) secretion rates in lean women and in obese women before and after 10% weight loss. VLDL-TG and VLDL-apoB-100 secretion rates were similar in lean and obese women. Weight loss decreased the rate of VLDL-TG secretion by ∼40% (from 0.41 ± 0.05 to 0.23 ± 0.03 μmol · kg fat-free mass−1 · min−1;P < 0.05). The relative decline in VLDL-TG produced from nonsystemic fatty acids, derived from intraperitoneal and intrahepatic TG, was greater (61 ± 7%) than the decline in VLDL-TG produced from systemic fatty acids, predominantly derived from subcutaneous TG (25 ± 8%; P < 0.05). Weight loss did not affect VLDL-apoB-100 secretion rate. We conclude that weight loss decreases the rate of VLDL-TG secretion in women with abdominal obesity, primarily by decreasing the availability of nonsystemic fatty acids. There is a dissociation in the effect of weight loss on VLDL-TG and apoB-100 metabolic pathways that may affect VLDL particle size.
American Physiological Society